Common medications in this class include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
Texas has no blanket prohibition on telehealth prescribing of controlled substances for weight loss
Tumor circadian clock strength influences metastatic potential and predicts patient prognosis in luminal A breast cancer
Seven binding proteins have been described (IGFBP-1 to -7)
A survey studying safety, efficacy, patient compliance and cost-effectiveness of transdermal, oral and intramuscular pain medication showed that all the patients experienced pain on injecting the drug